Patient access and pharma geo strategy

Event details

Date
Tuesday, 23 June - 18:00
Place
KPMG
Genre
Conferences
Organiser
INSEAD Alumni Association Switzerland
Patient access and pharma geo strategy - Conferences - KPMG

Description

Patient access and pharma geo strategy in the times of the game rules’changePresentations, panel discussion and Q&ATuesday, 23 June 2026   Recent health care reforms on pricing and access (IRA/MFN and tariffs in the US, JCA in Europe) are profoundly impacting how life sciences companies are operating globally. The changes in their geographic strategy and market prioritization trigger discussions regarding patient access to innovation in Europe. Our panel of experts will explore the current landscape of pharmaceutical market access and discuss how to navigate in times of uncertainty, touching a broad range of questions from competitiveness to patient access, including: What is the latest status of MFN/IRA? What impact on patient access do we see so far? What is their likely mid- and long-term impact? How are the roles of the EU and Switzerland changing? What could policy makers do? Is not launching in Europe a prudent business decision? How could pharmaceutical companies adapt, or even use the change for their benefit? Is there an opportunity in the transformation for health care providers and patients Programme 18:00 Arrival and networking18:15 Presentations, panel debate and Q&A19:30 Apéro & Networking21:00 Closing Key FactsWhen: Tuesday, 23 June 2026, 18:00Where: KPMG, Badenerstrasse 172, CH-8004 ZürichTickets: CHF 20 for NAA Members (paid-up), CHF 30 all other Alumni non-members and guests Ticketing closes 24h before the event. INSEAD Alumni Association SwitzerlandEvent organizers:Franziskus Kath, TIEMBA’10JanAmel Ounnoughene, MAP’12JunAleks Ruzicic, MBA’97Jevents@insead.ch  

  1. Home
  2. Patient access and pharma geo strategy